Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Clinical Haematology referrals

If you require general advice before sending a referral, we offer an email advice service.

Email: haematologyregistrar.enquiries@nhs.net

Electronic Referral System (ERS)

Previously known as 'Choose & Book'.

All referrals from GPs to Clinical Haematology must go through ERS. We accept referrals for both the Churchill and Horton sites. You can refer a patient via ERS on:

  • a Two Week Wait (2WW) pathway
  • an Urgent pathway
  • a Routine pathway.

Clinical Haematology is not a directly bookable service. Please refer the patient via ERS using the information below.

The Haematology Team will triage the referral on receipt and book the patient in for the most appropriate clinic.

The exception to this is Oxford Haemophilia and Thrombosis Centre (OHTC).

How to refer

To refer patient on a 2WW pathway, please ensure you select either of the below, depending on which site is most appropriate:

  • Suspected Haematological Cancer (Churchill)-RAS-Oxford University Hospitals-RTH
  • Suspected Haematological Cancer (Banbury)-RAS-Oxford University Hospitals-RTH

For an Urgent / Routine referral, please ensure you select either of the below, depending on which site is most appropriate:

  • Clinical Haematology-(Churchill)-Referral Assessment Service- Oxford University Hospitals-RTH
  • Clinical Haematology-(Banbury)-Referral Assessment Service- Oxford University Hospitals-RTH

MDT referrals

Blood and Marrow Transplant (BMT) MDT

Email: orh-tr.clinicalhaematology@nhs.net

The BMT MDT meeting is held twice monthly, every second and fourth Monday 12.00 noon - 1.30pm.

Dr Andy Peniket is the BMT Programme Director and the named clinician for the MDT.

The BMT MDT comprises:

  • Consultants from the Lymphoma, Myeloma and Myeloid teams
  • BMT Nurse Practitioner and Co-ordinators
  • BMT Fellow
  • Transplant Immunologist(s)
  • BMT MDT Co-ordinator.

In order to ensure that key members can participate, meetings take place via MS Teams.

Treatments are based on evidence-based guidelines and protocols available at the link below:

Network Site Specific Group (NSSG) - Haematology: BMT

Lymphoma MDT

Email: lymphomamdt@nhs.net

The Lymphoma MDT meeting is held weekly on Wednesday 1.00pm - 3.00pm.

Dr Graham Collins is the single named lead clinician for the MDT.

The Lymphoma MDT comprises consultants from a range of specialties including:

  • Chemotherapy
  • Radiotherapy
  • Radiology
  • Pathology (including molecular diagnostics).

These consultants, with the support of Advanced Nurse Practitioners and the wider team, deliver a service that includes the diagnosis and management of all new patients and agreed follow-up of patients with lymphoma within the Thames Valley.

Treatments are based on evidence-based guidelines and protocols available at the link below:

Network site specific group (NSSG) - Haematology: Lymphoma

Myeloid MDT

Email: myeloidmdt@nhs.net

The Myeloid MDT meeting is held weekly on Thursday.

The Regional meeting takes place at 11.30am - 12.30pm and alternates with the Local meeting which takes place 12.30pm -1.00pm.

Prof Paresh Vyas is the single named lead clinician for the MDT and Dr Adam Mead and Dr Andy Peniket are the Vice Chairs.

The Myeloid MDT comprises consultants from a range of specialties including:

  • Chemotherapy
  • Cytogenetics
  • Pathology (including molecular diagnostics).

These consultants, with the support of Advanced Nurse Practitioners and the wider team, deliver a service that includes the diagnosis and management of all new patients and agreed follow-up of patients with a myeloid disorder within the Thames Valley.

Treatments are based on evidence-based guidelines and protocols available at the link below:

Network site specific group (NSSG) - Haematology: Myloid

OXCOM Clinic - MGUS referrals

If you have been notified by the Monocolonal Gammopathy Pathway Team (based in the Immunology Lab), and asked to refer your patient to the OXCOM clinic due to a diagnosis of MGUS, please refer the patient via ERS on a routine referral.

Thames Valley Strategic Clinical Network - Low-Risk MGUS Pathway

Oxford Haemophilia and Thrombosis Centre

Anticoagulation Service

Email: ac.service@nhs.net

GP Anticoagulation Service referral form (Word, 49 KB)

If you have an nhs.net email account, please email the form securely to us at: ac.service@nhs.net

DVT Service

Email: dvt.service@nhs.net

DVT protocols - this link will only return a page if connected to the OUH network

These guidelines are approved for use within Oxford Haemophilia and Thrombosis Centre (OHTC) only and are presented here for reference only.

Directly Bookable Service for OHTC

The GP surgery will generate an appointment referral request with appropriate priority (urgent or routine) for the service on e-Referral and UBRN in the usual way.

To select a directly booked appointment, please see the guide at the link below, which shows how to use the system.

Directly Bookable Service quick guide (pdf, 720 KB)

An electronic proforma or appropriate letter needs to be attached to the e-Referral system by the surgery within 48 hours for a Routine or Urgent appointment.

In the case that the Trust cannot provide an immediate appointment, 'Defer to Provider' can be selected and Trust processes will be in place to contact the patient within 48 hours for an urgent or routine appointment.

For further information please visit 'e-Referral'.